Features of optical coherence tomography angiography in age-related macular degeneration with residual fluid after three loading doses of aflibercept
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Features of optical coherence tomography angiography in age-related macular degeneration with residual fluid after three loading doses of aflibercept ; volume:11 ; number:1 ; day:1 ; month:2 ; year:2024 ; pages:1-8 ; date:12.2024
Eye and Vision ; 11, Heft 1 (1.2.2024), 1-8, 12.2024
- Creator
-
Song, Yong-Yeon
Seong, Hyun-Je
Kim, Jung-Tae
Lee, Sung-Chul
Lee, Min-Woo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40662-023-00372-z
- URN
-
urn:nbn:de:101:1-2024031821040231015952
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Song, Yong-Yeon
- Seong, Hyun-Je
- Kim, Jung-Tae
- Lee, Sung-Chul
- Lee, Min-Woo
- SpringerLink (Online service)
Other Objects (12)
The effect of four loading intravitreal aflibercept injections on macular fluid in treatment-naïve neovascular age-related macular degeneration
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
Bilateral improvement in age-related macular degeneration following unilateral Aflibercept injection
Optical coherence tomography angiography biomarkers in a bi-monthly maintenance dosing aflibercept in patients with neovascular age-related macular degeneration
Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
The effect of four loading intravitreal aflibercept injections on macular fluid in treatment-naïve neovascular age-related macular degeneration
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
Bilateral improvement in age-related macular degeneration following unilateral Aflibercept injection
Optical coherence tomography angiography biomarkers in a bi-monthly maintenance dosing aflibercept in patients with neovascular age-related macular degeneration
Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
The effect of four loading intravitreal aflibercept injections on macular fluid in treatment-naïve neovascular age-related macular degeneration
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
Bilateral improvement in age-related macular degeneration following unilateral Aflibercept injection
Optical coherence tomography angiography biomarkers in a bi-monthly maintenance dosing aflibercept in patients with neovascular age-related macular degeneration
Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy